| Name | Title | Contact Details |
|---|
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.
“Big” doesn’t make us impersonal, it makes us better. Monitoring services are the heart and soul of the security business so our size equates to a higher comfort level with added redundancy and resources. Our highly trained staff provides your customer...
Qualiform Inc is a Wadsworth, OH-based company in the Business Services sector.
AIR MANAGEMENT SERVICES is a Albuquerque, NM-based company in the Business Services sector.
Cedar Ridge Research is a New Hope, AL-based company in the Business Services sector.